Loading clinical trials...

COMPLETEDPhase 1NCT05373901

Evaluation of the Safety and Pharmacokinetics of Dinutuximab Beta As Maintenance Therapy in Chinese Participants With High-Risk Neuroblastoma

This was an open-label, multi-center, single-arm, Phase 1 study. The purpose of this study was for evaluating the safety and pharmacokinetics of dinutuximab beta as maintenance therapy in Chinese part...

Lead sponsor: BeiGene•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

NCT06057948 · Neuroblastoma, High-risk Neuroblastoma, and more

WITHDRAWNNA

PediCARE Health Equity Intervention in High-Risk Neuroblastoma

NCT06335745 · Neuroblastoma, High-risk Neuroblastoma, and more

No Longer Available

Naxitamab and GM-CSF in People With Neuroblastoma

NCT04501757 · High-Risk Neuroblastoma

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 4, 2024Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment8

Start dateJun 2022

Last updatedOct 4, 2024

Condition

High-risk Neuroblastoma

Locations shown

Xinhua Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine

Shanghai, Shanghai Municipality

Tianjin Medical University Cancer Institute & Hospital

Tianjin, Tianjin Municipality

The Children's Hospital Zhejiang University School of Medicine

Hangzhou, Zhejiang

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 4, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions